Biogen Inc Annual Shareholders Meeting Transcript
Good day and welcome to the Biogen 2026 Annual Meeting of Stockholders.
I would now like to turn the conference over to Carolyn Dorsa. Please go ahead.
Thank you, Michael. Good morning. I am Carolyn Dorsa, Chair of the Board of Biogen, and I welcome you to Biogen's 2026 Annual Meeting of Stockholders.
I am here today with Wendell Taylor, Chief Corporate Counsel, who will act as Secretary of the meeting, and Christopher Viebacher, our President, Chief Executive Officer, and one of our Directors. I'm also joined by the other members of our board of directors, as well as members of the executive team of Biogen, including Ginger Gregory, Chief Human Resources Officer, Jane Grogan, Head of Research.
Rashid Izzar, Head of Global Product Strategy and Commercialization, Adam Kearney, Head of Corporate Development, Robin Kramer, Chief Financial Officer, Nicole Murphy, Head of Pharmaceutical Operations and Technology, and Priya Singhal, Head of Development. Mark Marsanti,
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

